25 May 2013
20 April 1992
Because pharmaceutical development times contain, of necessity, prescribed periods which are of similar duration for competing innovator companies (eg long-term...
20 April 1992
Alex Krauer, managing director of the Swiss chemical and pharmaceutical concern, Ciba-Geigy, has denied that his company could be about...
20 April 1992
User fee legislation is currently being drafted by the US Food and Drug Administration and could be ready for submission...
20 April 1992
The US market for products to diagnose, monitor and treat AIDS will grow from close to $300 million in 1991...
20 April 1992
A new improved vaccine directed against the bacterium responsible for bacterial meningitis and various other infectious diseases, Streptococcus pneumoniae ,...
20 April 1992
Four initiatives are to be implemented by the US Food and Drug Administration to speed access to new drugs and...
20 April 1992
John Petricciani, previously vice president for medical and regulatory affairs as the US Pharmaceutical Manufacturers Association, has moved to Genetics...
20 April 1992
Thomas Davis is elected to the board of directors at Celtrix Pharmaceuticals.
20 April 1992
Canadian biotechnology concern Cangene has applied for permission from the Canadian government to begin clinical testing of leucotropin, the company's...
20 April 1992
Researchers at the University of Texas Southwestern Medical Center in the USA have applied to the US Food and Drug...